Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewExemestane is an irreversible steroidal aromatase inhibitor (IC50 = 20 nM). Destabilizes aromatase and lowers estrogen levels; orally active.
Sold for research purposes under agreement from Pfizer Inc.
Exemestane is also offered as part of the Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
M. Wt | 296.4 |
Formula | C20H24O2 |
Storage | Store at -20°C |
Purity | ≥99% (HPLC) |
CAS Number | 107868-30-4 |
PubChem ID | 60198 |
InChI Key | BFYIZQONLCFLEV-DAELLWKTSA-N |
Smiles | C[C@@]12C(C(C[C@]3([H])[C@@]([H])2CC[C@@]4(C)[C@]([H])3CCC4=O)=C)=CC(C=C1)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 29.64 | 100 | |
ethanol | 22.23 | 75 |
The following data is based on the product molecular weight 296.4. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.37 mL | 16.87 mL | 33.74 mL |
5 mM | 0.67 mL | 3.37 mL | 6.75 mL |
10 mM | 0.34 mL | 1.69 mL | 3.37 mL |
50 mM | 0.07 mL | 0.34 mL | 0.67 mL |
References are publications that support the biological activity of the product.
Goss et al (2004) The steroidal aromatase inhibitor exeme. prevents bone loss in ovariectomized rats. Bone 34 384 PMID: 15003786
Wang and Chen (2006) Aromatase destabilizer: novel action of exemestane, a Food and Drug Administration-approved aromatase inhibitor. Cancer Res. 66 10281 PMID: 17079446
Miller et al (2008) Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist 13 829 PMID: 18695261
di Salle et al (1992) Exemestane (FCE 24304), a new steroidal aromatase inhibitor. J.Steroid Biochem.Mol.Biol. 43 137 PMID: 1525055
If you know of a relevant reference for Exemestane, please let us know.
Keywords: Exemestane, Exemestane supplier, Pfizer, aromatase, inhibitors, inhibits, estrogen, synthesis, CYP19, Cytochrome, P450, FCE24304, FCE, 24304, EXE, 3759, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Exemestane. Do you know of a great paper that uses Exemestane from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Exemestane and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image